Drug Profile
Ligustrazine ferulic acid acetate - Jiangbo Pharmaceuticals
Alternative Names: LFAA; Liqustrazine ferulic acid acetateLatest Information Update: 21 Aug 2018
Price :
$50
*
At a glance
- Originator Shandong University
- Developer Jiangbo Pharmaceuticals
- Class Antithrombotics; Pyrazines; Small molecules
- Mechanism of Action Fibrinolytic agents; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 21 Aug 2018 Discontinued - Preclinical trials for Thrombosis in China (unspecified route)